Safety and Efficacy Study of the Combined Ablation Procedure to Treat Paroxysmal Atrial Fibrillation (CAP STOPS AF)
Feasibility Study For Safety and Efficacy Evaluation Of The Combined Ablation Procedure For The Treatment Of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Sponsor: nContact Surgical Inc.
Terminated
enrollment challenges, only one patient enrolled
Other terminated trials from nContact Surgical Inc.
More terminations from nContact Surgical Inc.
Other Paroxysmal Atrial Fibrillation trials with similar outcome
A NA clinical study on Paroxysmal Atrial Fibrillation, this trial is terminated or withdrawn. The trial is conducted by nContact Surgical Inc. and has accumulated 6 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- nContact Surgical Inc.
For direct contact, visit the study record on ClinicalTrials.gov .